Moderna jumped roughly 200% on its skin cancer drug advancing to the next trial phase and, after consolidating, has stepped higher, but it just printed its biggest red candle since that jump and the RSI is diverging bearishly against higher price highs; a decline would not surprise him and he would not fight that move.

We'll take a look at SpaceX and Moderna,

Then we have a "cancer cure" candle, right? Or that leap in the candle there . Okay, this is Moderna. You see that they got that good treatment for skin cancer, you know, move on to the next trial.

The skin cancer drug, of course, moved on to the next phase of trials. The stock jumped based on that news.

I mean, this, you know, 100% means doubling the price. That was almost three times the price. It was a movement of approximately 200%. Now, as you know, the price has consolidated and started to take an additional step upwards.

But, since that candle, since, I don't know, I think you call it a cancer healing candle. I don't know. Um, I'm not trying to make light of it . This is essentially what happened to the stock there.

This is the biggest red candle we've seen since that jump over there.

But what about the Relative Strength Index (RSI)? The RSI indicator was giving bearish signals. You can see the price, and I almost rule that out . You can simply enlarge the image directly here.

The price was making higher highs, but the RSI indicator was trending downwards. This is what they call downward deviation. So , I wouldn't be surprised if we started to see a decline in Moderna's stock.

I would be careful not to try to stand in front of this express freight train.

These are our most important moves for today. I hope this helps you, especially as we head towards next week. So, keep an eye on those key levels.